Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph DeSimone

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Seminars in Hematology|March 31, 2005
The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemiaJoseph DeSimone
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Approaches to the reactivation of hemoglobin F as a treatment for sickle cell diseaseJoseph DeSimone
Multimedia Manual of Cardiothoracic Surgery : MMCTS|January 14, 2014
Off-pump myocardial revascularizationJoseph Desimone, Paul Sergeant
Seminars in Hematology|November 10, 2004
Clinical studies with fetal hemoglobin-enhancing agents in sickle cell diseaseYogen Saunthararajah, Joseph DeSimone
Angewandte Chemie (International Ed. in English)|May 2, 2018
CO<sub>2</sub> Technology Platform: An Important Tool for Environmental Problem SolvingSharon L Wells, Joseph DeSimone
Angewandte Chemie (International Ed. in English)|February 17, 2001
CO(2) Technology Platform: An Important Tool for Environmental Problem Solving A list of abbreviations can be found at the end of the articleSharon L. Wells, Joseph DeSimone
Seminars in Hematology|January 29, 2021
Epigenetic regulation of hemoglobin switching in non-human primatesRobert Molokie, Joseph DeSimone, Donald Lavelle
British Journal of Haematology|August 26, 2004
DNA hypo-methylating agents and sickle cell diseaseYogen Saunthararajah, Donald Lavelle, Joseph DeSimone
Blood|February 12, 2008
DNA methylation and mechanism of action of 5-azacytidineDonald Lavelle, Yogen Saunthararajah, Joseph Desimone
Nanomedicine (London, England)|December 25, 2010
The Carolina Center of Cancer Nanotechnology Excellence: past accomplishments and future perspectivesRudy L Juliano, Susan Sunnarborg, Joseph DeSimone, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Seminars in Hematology|March 31, 2005
The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemiaJoseph DeSimone
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Approaches to the reactivation of hemoglobin F as a treatment for sickle cell diseaseJoseph DeSimone
Multimedia Manual of Cardiothoracic Surgery : MMCTS|January 14, 2014
Off-pump myocardial revascularizationJoseph Desimone, Paul Sergeant
Seminars in Hematology|November 10, 2004
Clinical studies with fetal hemoglobin-enhancing agents in sickle cell diseaseYogen Saunthararajah, Joseph DeSimone
Angewandte Chemie (International Ed. in English)|May 2, 2018
CO<sub>2</sub> Technology Platform: An Important Tool for Environmental Problem SolvingSharon L Wells, Joseph DeSimone
Angewandte Chemie (International Ed. in English)|February 17, 2001
CO(2) Technology Platform: An Important Tool for Environmental Problem Solving A list of abbreviations can be found at the end of the articleSharon L. Wells, Joseph DeSimone
Seminars in Hematology|January 29, 2021
Epigenetic regulation of hemoglobin switching in non-human primatesRobert Molokie, Joseph DeSimone, Donald Lavelle
British Journal of Haematology|August 26, 2004
DNA hypo-methylating agents and sickle cell diseaseYogen Saunthararajah, Donald Lavelle, Joseph DeSimone
Blood|February 12, 2008
DNA methylation and mechanism of action of 5-azacytidineDonald Lavelle, Yogen Saunthararajah, Joseph Desimone
Nanomedicine (London, England)|December 25, 2010
The Carolina Center of Cancer Nanotechnology Excellence: past accomplishments and future perspectivesRudy L Juliano, Susan Sunnarborg, Joseph DeSimone, et al.
Pageof 6